Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orfadin and Nitinosine Study

NCT04113772 is registered in ClinicalTrials.gov with Sutphin Drugs as lead sponsor.

NCT NCT04113772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04113772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orfadin and Nitinosine Study
Lead sponsor
Sutphin Drugs
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2019
Completion date
March 31, 2021
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary tyrosinemia, type i